Publications by authors named "Anne Pradines"

Claim this Profile
F
Fast enrichment and detection of circulating tumor cells from large volumes of whole blood of breast cancer patients utilizing a functionalized bioaffinity CTC filtration membrane.
Leonie F Ott, Laura Keller, Nathan Bentley, Hümeyra Husseini-Wüsthoff, René Werner, Anne Pradines

Int J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of EGFR mutations at pM concentration in ten minutes using a microfluidic concentration and separation module.
Jeffrey Teillet, Anne Pradines, Naima Hanoun, Jules Edwards, Pierre Joseph

Biomed Microdevices· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients.
Charlotte Maulat, Cindy Canivet, Bastien Cabarrou, Anne Pradines, Janick Selves

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomics profiling of the non-small cell lung cancer microenvironment across disease stages reveals dual immune cell-type behaviors.
Marcelo Hurtado, Leila Khajavi, Abdelmounim Essabbar, Michael Kammer, Ting Xie, Anne Pradines

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies.
Sarah Figarol, Célia Delahaye, Rémi Gence, Aurélia Doussine, Juan Pablo Cerapio, Anne Pradines

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Size and Concentration of Cell-Free DNA Measured Directly from Blood Plasma, without Prior DNA Extraction.
Audrey Boutonnet, Anne Pradines, Marion Mano, Marion Kreczman-Brun, Julien Mazières

Anal Chem· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
François-Clément Bidard, Anne-Claire Hardy-Bessard, Florence Dalenc, Thomas Bachelot, Jean-Yves Pierga, Anne Pradines

Lancet Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells.
Arnaud Carrier, Cécile Desjobert, Valérie Lobjois, Lise Rigal, Florence Busato, Anne Pradines

Clin Epigenetics· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer.
Celia Delahaye, Sarah Figarol, Anne Pradines, Gilles Favre, Julien Mazieres

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS.
Celine Callens, Francois-Clement Bidard, Anaïs Curto-Taribo, Olfa Trabelsi-Grati, Samia Melaabi, Anne Pradines

Anal Chem· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1.
Frédérique Berger, Margaux Marce, Suzette Delaloge, Anne-Claire Hardy-Bessard, Thomas Bachelot, Anne Pradines

BMJ Open· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC).
Fabrizio Tabbò, Chiara Pisano, Julien Mazieres, Laura Mezquita, Ernest Nadal, Anne Pradines

Cancer Treat Rev· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, biology and epidemiology of oligometastatic breast cancer.
Jean-Louis Lacaze, Richard Aziza, Ciprian Chira, Eleonora De Maio, Françoise Izar, Anne Pradines

Breast· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Tumor Recurrence via Circulating Tumor DNA Profiling in Patients with Localized Lung Cancer: Clinical Considerations and Challenges.
Bryan Ulrich, Anne Pradines, Julien Mazières, Nicolas Guibert

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease Monitoring Using a 3'ALK Universal Probe Assay in ALK-Positive Anaplastic Large-Cell Lymphoma: ddPCR, an Attractive Alternative Method to Real-Time Quantitative PCR.
Cathy Quelen, David Grand, Emeline Sarot, Laurence Brugières, David Sibon, Anne Pradines

J Mol Diagn· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with -Mutant Metastatic Non-Small Cell Lung Cancer.
Sandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, Mihalea Aldea, Julien Mazieres, Anne Pradines

Clin Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!
Lucile Durin, Anne Pradines, Céline Basset, Bryan Ulrich, Laura Keller

Cells· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Finding mutations of interest in circulating tumor DNA helps predict immunotherapy response in lung cancer].
Nicolas Guibert, Anne Pradines, Gilles Favre, Julien Mazières

Med Sci (Paris)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.
Nicolas Guibert, Anne Pradines, Gilles Favre, Julien Mazieres

Eur Respir Rev· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
Nicolas Guibert, Greg Jones, John F Beeler, Vincent Plagnol, Clive Morris, Anne Pradines

Lung Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.
Laura Keller, Nicolas Guibert, Anne Casanova, Stephanie Brayer, Magali Farella, Anne Pradines

Acta Derm Venereol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic p27 promotes tumorigenesis via suppression of RhoB activity.
Olivier Calvayrac, Ada Nowosad, Stéphanie Cabantous, Lin-Po Lin, Sarah Figarol, Anne Pradines

J Pathol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.
Nicolas Guibert, Myriam Delaunay, Amélie Lusque, Nadia Boubekeur, Isabelle Rouquette, Anne Pradines

Lung Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The Ras-related GTPase RhoB, a relevant actor in the adaptive resistance to EGFR tyrosine kinase inhibitors in lung cancers].
Olivier Calvayrac, Anne Pradines, Julien Mazières, Gilles Favre

Med Sci (Paris)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating cell-free microRNAs as clinical cancer biomarkers.
Virginie Armand-Labit, Anne Pradines

Biomol Concepts· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis